Fig. 8: Illustration.
From: Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death
Biological outcomes of ERK-MYD88 PPI vs ERK enzymatic inhibition.
Fig. 8: Illustration. | Nature Communications
From: Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death
Biological outcomes of ERK-MYD88 PPI vs ERK enzymatic inhibition.
